Nutex Health, Inc. (NUTX)
USD 66.86
(-6.32%)
USD 66.86
(-6.32%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -14.58 Million USD | 103.91% |
| 2022 | -393.96 Million USD | -95.72% |
| 2021 | 183.44 Million USD | 18.33% |
| 2020 | -5.11 Million USD | 314.6% |
| 2019 | -6.84 Million USD | 2181.19% |
| 2018 | -839.8 Thousand USD | 67.84% |
| 2017 | -5.1 Million USD | -1170.37% |
| 2016 | -448 Thousand USD | 15.82% |
| 2015 | -532.32 Thousand USD | 0.0% |
| 2011 | -844.57 Thousand USD | 37.26% |
| 2010 | -1.34 Million USD | -96.82% |
| 2009 | -683.98 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 5.63 Million USD | 138.91% |
| 2024 Q2 | 16.5 Million USD | 59.14% |
| 2023 Q4 | 8.75 Million USD | 120.74% |
| 2023 Q1 | -193.53 Thousand USD | 96.77% |
| 2023 Q2 | 3.81 Million USD | 2070.87% |
| 2023 Q3 | 3.96 Million USD | 4.04% |
| 2023 FY | - USD | 103.91% |
| 2022 Q2 | 9.21 Million USD | 157.07% |
| 2022 Q3 | -25.58 Million USD | -377.78% |
| 2022 FY | - USD | -95.72% |
| 2022 Q1 | -16.13 Million USD | -187.95% |
| 2022 Q4 | -5.99 Million USD | 76.58% |
| 2021 FY | - USD | 18.33% |
| 2021 Q2 | 35.6 Million USD | 971.57% |
| 2021 Q4 | 18.34 Million USD | -76.5% |
| 2021 Q3 | 78.07 Million USD | 119.32% |
| 2021 Q1 | -4.08 Million USD | -106.38% |
| 2020 Q2 | -1.68 Million USD | -79.02% |
| 2020 Q4 | 64.03 Million USD | 10295.41% |
| 2020 FY | - USD | 314.6% |
| 2020 Q1 | -939.91 Thousand USD | 83.77% |
| 2020 Q3 | -628.03 Thousand USD | 62.67% |
| 2019 Q4 | -5.79 Million USD | -1492.36% |
| 2019 FY | - USD | 2181.19% |
| 2019 Q1 | -367.11 Thousand USD | 34.74% |
| 2019 Q3 | -363.75 Thousand USD | 2.92% |
| 2019 Q2 | -374.7 Thousand USD | -2.07% |
| 2018 Q1 | -411.96 Thousand USD | 88.21% |
| 2018 Q4 | -562.57 Thousand USD | -53.28% |
| 2018 FY | - USD | 67.84% |
| 2018 Q3 | -367.01 Thousand USD | 24.95% |
| 2018 Q2 | -489 Thousand USD | -18.7% |
| 2017 Q2 | -1.24 Million USD | 0.0% |
| 2017 Q3 | -711.94 Thousand USD | 42.98% |
| 2017 FY | - USD | -1170.37% |
| 2017 Q4 | -3.49 Million USD | -390.64% |
| 2016 FY | - USD | 15.82% |
| 2015 FY | - USD | 0.0% |
| 2011 Q4 | -239.67 Thousand USD | -0.13% |
| 2011 Q1 | -170.71 Thousand USD | 61.78% |
| 2011 Q2 | -194.81 Thousand USD | -14.11% |
| 2011 Q3 | -239.37 Thousand USD | -22.87% |
| 2011 FY | - USD | 37.26% |
| 2010 FY | - USD | -96.82% |
| 2010 Q4 | -446.71 Thousand USD | -44.05% |
| 2010 Q3 | -310.09 Thousand USD | -11.02% |
| 2010 Q1 | -310.09 Thousand USD | 0.0% |
| 2010 Q2 | -279.3 Thousand USD | 9.93% |
| 2009 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CareCloud, Inc. | -31.29 Million USD | 53.399% |
| Augmedix, Inc. | -17.68 Million USD | 17.531% |
| BrightSpring Health Services, Inc. Common Stock | 349.51 Million USD | 104.172% |
| CareCloud, Inc. | -31.29 Million USD | 53.399% |
| HealthEquity, Inc. | 282.41 Million USD | 105.163% |
| iCoreConnect Inc. | -11.87 Million USD | -22.745% |
| Inovalon Holdings, Inc. | 186.56 Million USD | 107.816% |
| Omnicell, Inc. | 60.69 Million USD | 124.026% |
| OneMedNet Corporation | -11.97 Million USD | -21.808% |
| Progyny, Inc. | 64.46 Million USD | 122.619% |
| Renalytix Plc | -28.52 Million USD | 48.875% |
| Schrödinger, Inc. | -171.89 Million USD | 91.517% |
| Simulations Plus, Inc. | 6.13 Million USD | 337.83% |
| SOPHiA GENETICS SA | -70.7 Million USD | 79.376% |
| Streamline Health Solutions, Inc. | -12.81 Million USD | -13.775% |
| Ontrak, Inc. | -14.41 Million USD | -1.147% |
| GE HealthCare Technologies Inc. | 3.56 Billion USD | 100.41% |
| Sharecare, Inc. | -67.25 Million USD | 78.319% |
| Aclarion, Inc. | -4.14 Million USD | -252.172% |
| CareMax, Inc. | -590.46 Million USD | 97.531% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.27 Million USD | -176.421% |
| Forian Inc. | 2.75 Million USD | 630.175% |
| Bullfrog AI Holdings, Inc. Warrants | -5.27 Million USD | -176.421% |
| HeartBeam, Inc. | 675 Thousand USD | 2260.201% |
| GeneDx Holdings Corp. | -136.46 Million USD | 89.315% |
| SCWorx Corp. | -3.97 Million USD | -266.855% |
| Minerva Surgical, Inc. | -20.07 Million USD | 27.358% |
| Definitive Healthcare Corp. | -241.22 Million USD | 93.955% |
| 10x Genomics, Inc. | -205.11 Million USD | 92.891% |
| Zhongchao Inc. | -4.9 Million USD | -197.436% |
| Accolade, Inc. | -71.19 Million USD | 79.519% |
| MSP Recovery, Inc. | -69.22 Million USD | 78.935% |
| R1 RCM Inc. | 426.2 Million USD | 103.421% |
| Spok Holdings, Inc. | 26.29 Million USD | 155.449% |
| Privia Health Group, Inc. | 27.18 Million USD | 153.643% |
| EUDA Health Holdings Limited | -8.3 Million USD | -75.671% |
| TruBridge, Inc. | -15.39 Million USD | 5.261% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 349.51 Million USD | 104.172% |
| Sharecare, Inc. | -67.25 Million USD | 78.319% |
| Health Catalyst, Inc. | -66.46 Million USD | 78.061% |
| GoodRx Holdings, Inc. | 108.82 Million USD | 113.399% |
| Premier, Inc. | 286.08 Million USD | 105.097% |
| HealthStream, Inc. | 59.58 Million USD | 124.471% |
| Certara, Inc. | 23.84 Million USD | 161.153% |
| GeneDx Holdings Corp. | -136.46 Million USD | 89.315% |
| Ontrak, Inc. | -14.41 Million USD | -1.147% |
| SHL Telemedicine Ltd. | 3.28 Million USD | 544.078% |
| CareCloud, Inc. | -31.29 Million USD | 53.399% |
| EUDA Health Holdings Limited | -8.3 Million USD | -75.671% |
| HeartBeam, Inc. | 675 Thousand USD | 2260.201% |
| Mangoceuticals, Inc. | -9.18 Million USD | -58.708% |
| CareMax, Inc. | -590.46 Million USD | 97.531% |
| Healthcare Triangle, Inc. | -4.1 Million USD | -255.296% |
| National Research Corporation | 45.98 Million USD | 131.709% |
| Aclarion, Inc. | -4.14 Million USD | -252.172% |
| OptimizeRx Corporation | -21.3 Million USD | 31.57% |